PTIX
Protagenic Therapeutics, Inc.\new
Latest Form 4:Purchase$945byARMEN GARO H (EXEC. CHAIR & PRINCIPAL OFF) · filed Aug 20, 2026
Protagenic Therapeutics, Inc.\new (PTIX) has 5 SEC Form 4 filings (5 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 20, 2026.
The most active filer is EXEC. CHAIR & PRINCIPAL OFF ARMEN GARO H with 5 filings.
- Industry:Biotechnology
- CEO:Garo H. Armen
- Employees:1
- HQ:Santa Barbara, CA, US
- IPO:2021-04-27
Insider Buying
$8K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$652K
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| EXEC. CHAIR & PRINCIPAL OFF | Purchase | 2,700 | $945 | Aug 20 | SEC ↗ | |
| EXEC. CHAIR & PRINCIPAL OFF | Purchase | 2,220 | $710 | Aug 12 | SEC ↗ | |
| EXEC. CHAIR & PRINCIPAL OFF | Purchase | 685 | $151 | Aug 10 | SEC ↗ | |
| EXEC. CHAIR & PRINCIPAL OFF | Purchase | 5,000 | $1K | Aug 7 | SEC ↗ | |
ARMEN GARO HFirst filing | EXEC. CHAIR & PRINCIPAL OFF. | Purchase | 26,291 | $5K | Aug 3 | SEC ↗ |
Related companies
Protagenic Therapeutics, Inc.\new is in the Healthcare sector.